PMC/PubMed Indexed Articles
Indexed In
- Academic Journals Database
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- CiteFactor
- Scimago
- Ulrich's Periodicals Directory
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- MIAR
- University Grants Commission
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Bioequivalence & Bioavailability have been cited by esteemed scholars and scientists all around the world. Journal of Bioequivalence & Bioavailability has got h-index 26, which means every article in Journal of Bioequivalence & Bioavailability has got 26 average citations.
Following are the list of articles that have cited the articles published in Journal of Bioequivalence & Bioavailability.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 57 | 60 | 61 | 19 | 6 | 27 | 57 | 60 | 62 | 46 | 60 | 47 | 71 | 27 | 21 |
Research, Review articles and Editorials |
6 | 11 | 18 | 20 | 9 | 5 | 17 | 44 | 50 | 50 | 33 | 39 | 17 | 64 | 27 | 17 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
34 | 46 | 42 | 41 | 10 | 1 | 10 | 13 | 10 | 12 | 13 | 23 | 30 | 7 | 0 | 4 |
Conference proceedings |
0 | 0 | 0 | 0 | 21 | 11 | 72 | 40 | 62 | 44 | 89 | 112 | 250 | 144 | 97 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
254 | 315 | 394 | 412 | 405 | 380 | 363 | 384 | 615 | 378 | 376 | 169 | 96 | 170 | 0 | 0 |
| Journal total citations count | 4890 |
| Journal impact factor | 6.89 |
| Journal 5 years impact factor | 11.60 |
| Journal cite score | 14.43 |
| Journal h-index | 26 |
Important citations
Jouan-Hureaux V (2011) Les thérapies ciblées anti-EGFR ont-elles un réel effet anti-angiogénique? Etude in vitro de l'angiogenèse induite par des cellules cancéreuses des VADS traitées ou non par le Cetuximab (Doctoral dissertation, Université Henri Poincaré-Nancy 1).
Razzaq A, Imran Qadir MD (2018) Cancer: From Theory to Practice–Ideology of Etiology and Treatment. BAOJ Biotech 4:034.
Joshi HP (2011) Non-canonical pathways of HIF1-alpha regulation in ovarian cancer: implications for tumor angiogenesis and metastasis.
Sudhakar A (2009) History of Cancer, Ancient and Modern Treatment Methods. J Cancer Sci Ther 1: i-iv. doi: 10.4172/1948-5956.100000 e2 the discovery of DNA helical structure. Later scientists learned how genes were worked and how they could be damaged by mutations. Scientists identified that cancer could be caused by chemicals (carcinogens), radiation, viruses and also inherited from ancestors. Most carcinogens were damage the DNA, which led to abnormal growth of cells. Cancer cells with damaged DNA do not die, where as normal cells with damaged DNA die. During the 1970s, scientists discovered 2.
da Silva Ulpiano C (2018) RNAi as a tool to inhibit the angiogenic potential of human Mesenchymal Stem/Stromal Cells in malignancy.
Sharma M (2018) Cancer and Its Root Causes-A Historical Analysis. Int J Res 5:272-279.
Verma RK, Gunda V, Pawar SC, Sudhakar YA (2013) Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis. PloS one 8:e80555.
Gunda V, Verma RK, Sudhakar YA (2013) Inhibition of elastin peptide-mediated angiogenic signaling mechanism (s) in choroidal endothelial cells by the α6 (IV) NC1 collagen fragment. Invest Ophthalmol Vis Sci 54:7828-7835.
Boosani CS, Varma AK, Sudhakar A (2010) Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities. J Cancer Sci Ther 2009:8.
Sudhakar A (2009) History of Cancer, Ancient and Modern Treatment Methods. J Cancer Sci Ther 1:1-4.
Damodar R, Movva B (2014) Preparation and.
Shalini K. Research & Reviews: Journal of Pharmacology and Toxicological Studies.
Epifano F, Genovese S, Carlucci G, Locatelli M (2012) Novel Prodrugs for the Treatment of Colonic Diseases Based on 5-Aminosalicylic Acid, 4'-eranyloxyferulic Acid, and Auraptene: Biological Activities and Analytical Assays. Curr Drug Deliv 9:112-121.
Renati D, Vinay CV (2014) Role of Novel Hole Technology in Fast Dissolving Tablets. Journal of Molecular Pharmaceutics & Organic Process Research.
Damodar R, Movva B, Mallikarjun PN, Pasumarthy C, Kona N, Varsha PV (2014) Formulation and evaluation of fast dissolving tablets of diclofenac sodium by novel hole technology. J Mol Pharm Org Process Res 2:2-6.
BASAVARAJ S (2012) SYNTHESIS AND CHARACTERIZATION OF GUAR GUM DERIVATIES FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF ACECLOFENAC (Doctoral dissertation).
Al Haydar M, Abid HR, Sunderland B, Wang S (2019) Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate. Drug Design Develop Ther 13:23.
Nagpal M, Aggarwal G, Sharma P, Mahan P, Thakur GS (2017) Neem Gum Based Solid Dispersion in Development of Aceclofenac Tablet with Enhanced Bioavailability. Drug Deliv Lett 7:115-124.
Damodar R, Movva B (2014) Preparation and.
Panigrahi PP (2013) Solubility Enhancement of Poorly Water Soluble Drug Celecoxib. Pharma Tutor 1:53-64.